Fast Five Quiz: Tea and Health

Elwyn C. Cabebe, MD; Helmi L. Lutsep, MD; Yasmine S. Ali, MD, MSCI


August 03, 2022

Studies have shown that dietary flavonoids, including those found in green tea, should be avoided in patients taking bortezomib as a chemotherapeutic drug. Bortezomib inhibits proteasome and is used for treatment in patients with relapsed and refractory multiple myeloma.

Green tea extract has shown potential heart protection in patients taking doxorubicin. Patients with rheumatoid arthritis taking infliximab who also consumed green tea have shown additional clinical improvement. No consensus has been reached about green tea and gabapentin.

Learn more about indications and considerations regarding green tea.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.